Evaluation of C1q genomic region in minority racial groups of lupus

Genes and Immunity

Volumn 10, Issue 5, 2009, Pages 517-524

  Namjou, B ^a   Gray McGuire, C ^a   Sestak, A L ^a   Gilkeson, G S ^b   Jacob, C O ^c   Merrill, J T ^a   James, J A ^a,g   Wakeland, E K ^d   Li, Q Z ^d   Langefeld, C D ^e   Divers, J ^e   Ziegler, J ^e   Moser, K L ^a   Kelly, J A ^a   Kaufman, K M ^a,f   Harley, J B ^a,f,g  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3;

ADULT; AFRICAN AMERICAN; ARTICLE; CHROMOSOME 1; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPIC VARIATION; PHOTOSENSITIVITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

AFRICAN AMERICANS; COMPLEMENT C1Q; GENETIC PREDISPOSITION TO DISEASE; HISPANIC AMERICANS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; OKLAHOMA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 67849097195     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.33     Document Type: Article

References (29)

1. Hauptmann G, Grosshans E, Heid E. Lupus erythematosus syndrome and complete deficiency of the fourth component of complement. Boll Ist Sieroter Milan 1974; 53(Suppl): 228.
2. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 2000; 76: 227-324.
3. Hannema AJ, Kluin-Nelemans JC, Hack CE, Eerenberg-Belmer AJ, Mallée C, van Helden HP. SLE like syndrome and functional deficiency of C1q in members of a large family. Clin Exp Immunol 1984; 55: 106-114.
4. Carroll MC. The complement system in B cell regulation. Mol Immunol 2004; 41: 141-146.
5. Bird P, Lachmann PJ. The regulation of IgG subclass production in man: low serum IgG4 in inherited deficiencies of the classical pathway of C3 activation. Eur J Immunol 1988; 18: 1217-1222.
6. Glass D, Raum D, Gibson D, Stillman JS, Schur PH. Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest 1976; 58: 853-861.
7. Lachmann PJ. Genetic deficiencies of the complement system. Boll Ist Sieroter Milan 1974; 53(Suppl): 195-207.
8. Brai M, Accardo P, Bellavia D. Polymorphism of the complement components in human pathology. Ann Ital Med Int 1994; 3: 167-172.
9. Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology 1998; 199: 265-285.
10. Petry F, Hauptmann G, Goetz J, Grosshans E, Loos M. Molecular basis of a new type of C1q-deficiency associated with a non-functional low molecular weight (LMW) C1q: Parallels and differences to other known genetic C1q-defects. Immunopharmacology 1997; 38: 189-201.
11. Racila DM, Sontheimer CJ, Sheffield A, Wisnieski JJ, Racila E, Sontheimer RD. Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus. Lupus 2003; 12: 124-132.
12. Sellar GC, Blake DJ, Reid KB. Characterization and organization of the genes encoding the A-, B-, and C-chains of human complement subcomponent C1q: The complete derived amino acid sequence of human C1q. Biochem J 1991; 274: 481-490.
13. Vilá LM, Alarcón GS, McGwin Jr G, Bastian HM, Fessler BJ, Reveille JD et al. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: Association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum 2006; 5: 799-806.
14. Hoffman IE, Peene I, Meheus L, Huizinga TW, Cebecauer L, Isenberg D et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 2004; 9 1155-1158.
15. Chew CH, Chua KH, Lian LH, Puah SM, Tan SY. PCR-RFLP genotyping of C1q mutations and single nucleotide polymorphisms in Malaysian patients with systemic lupus erythematosus. Hum Biol 2008; 80: 83-93.
16. Martens HA, Zuurman MW, de Lange AH, Nolte IM, van der Steege G, Navis GJ et al. Analysis of C1q polymorphisms suggests association with SLE, serum C1q and CH50 levels and disease severity. Ann Rheum Dis 2009; 68: 715-720. 26 May 2008.
17. Petry F, Loos M. Common silent mutations in all types of hereditary complement C1q deficiencies. Immunogenetics 2005; 57: 566-571. e-pub 29 September 2005.
18. Miura-Shimura Y, Nakamura K, Ohtsuji M, Tomita H, Jiang Y, Abe M et al. C1q regulatory region polymorphism down-regulating murine c1q protein levels with linkage to lupus nephritis. J Immunol 2002; 169: 1334-1339.
19. Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA. Anti-C1q antibodies in nephritis: Correlation between titers and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 444-448.
20. Racila E, Link BK, Weng WK, Witzig TE, Ansell S, Maurer MJ et al. A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma. Clin Cancer Res 2008; 14: 6697-6703.
21. Racila E, Racila DM, Ritchie JM, Taylor C, Dahle C, Weiner GJ. The pattern of clinical breast cancer metastasis correlates with a single nucleotide polymorphism in the C1qA component of complement. Immunogenetics 2006; 1: 1-8.
22. Kaufman KM, Kelly JA, Herring BJ, Adler AJ, Glenn SB, Namjou B et al Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2533-2540.
23. Jacob CO, Reiff A, Armstrong DL, Myones BL, Silverman E, Klein-Gitelman M et al. Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform. Arthritis Rheum 2007; 56: 4164-4173.
24. Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Cohen PL et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 2002; 3: 161-167.
25. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
26. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D et al. PLINK: A toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007; 81: 559-575.
27. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 263-265.
28. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.
29. Harley JB, Alarcón-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 2: 204-210.